Increased proteolysis of antithrombin III Vicenza during disseminated intravascular coagulation in acute leukemia

Thromb Res. 1989 Sep 1;55(5):661-4. doi: 10.1016/0049-3848(89)90400-3.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Antithrombin III / metabolism*
  • Antithrombin III Deficiency*
  • Cytarabine / administration & dosage
  • Daunorubicin / administration & dosage
  • Disseminated Intravascular Coagulation / blood*
  • Disseminated Intravascular Coagulation / etiology
  • Female
  • Fibrin Fibrinogen Degradation Products / analysis
  • Fibrinogen / analysis
  • Humans
  • Leukemia, Myeloid, Acute / blood*
  • Leukemia, Myeloid, Acute / complications
  • Leukemia, Myeloid, Acute / drug therapy
  • Thioguanine / administration & dosage
  • Thrombin / metabolism
  • Thrombophlebitis / genetics

Substances

  • Fibrin Fibrinogen Degradation Products
  • antithrombin III Vicenza
  • Cytarabine
  • Antithrombin III
  • Fibrinogen
  • Thrombin
  • Thioguanine
  • Daunorubicin

Supplementary concepts

  • DAT protocol 1